IDHQ - ETF AI Analysis
Top Page
Invesco S&P International Developed High Quality ETF (IDHQ)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past three months, showing solid recent momentum.
High-Quality Leading Holdings
Several of the largest positions, such as ASML, ABB, and Advantest, have shown strong performance, helping drive the fund’s returns.
Broad International Diversification
The fund spreads its investments across many developed countries, including Switzerland, Japan, the UK, the U.S., and others, reducing reliance on any single market.
Negative Factors
Heavy Exposure to a Few Countries
A large share of assets is concentrated in a handful of markets like Switzerland, Japan, and the UK, which can increase risk if those economies weaken.
Top Holdings Concentration
The biggest positions, especially ASML and other large stocks, make up a meaningful portion of the portfolio, so problems at these companies could noticeably affect the ETF.
Moderate Expense Ratio
The fund’s expense ratio is not especially low for a passive ETF, which slightly reduces the net return investors keep over time.
IDHQ vs. SPDR S&P 500 ETF (SPY)
AUM1.07B
RegionDeveloped Markets
Expense Ratio0.29%
Beta0.82
IssuerInvesco
Inception DateJun 13, 2007
Dividend Yield2.01%
Asset ClassEquity
Index TrackedS&P Quality Developed Ex-U.S. LargeMidCap Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume163,497
30 Day Avg. Volume149,310
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
52.05Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering199
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IDHQ Summary
IDHQ is the Invesco S&P International Developed High Quality ETF, which follows the S&P Quality Developed Ex-U.S. LargeMidCap Index. It invests in strong, established companies from developed countries outside the U.S., with big positions in places like Switzerland, Japan, and the UK. Well-known holdings include ASML Holding and Nestlé. Investors might consider IDHQ to add international diversification and focus on financially solid companies that have shown steady performance over time. A key risk is that these international stocks can still rise and fall with global markets and currency swings, so the value of the ETF can go up and down.
How much will it cost me?The Invesco S&P International Developed High Quality ETF (IDHQ) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specialized strategy of selecting high-quality international companies. The added cost reflects the fund's meticulous approach to targeting financially strong firms.
What would affect this ETF?Positive drivers for IDHQ include potential growth in developed markets outside the U.S., particularly in sectors like healthcare and technology, which are heavily weighted in the ETF and often benefit from innovation and stable demand. However, negative factors could arise from global economic slowdowns, regulatory changes in key regions, or currency fluctuations that impact international companies' profitability. The ETF's focus on high-quality companies may help mitigate risks but does not eliminate exposure to broader market challenges.
IDHQ Top 10 Holdings
IDHQ is leaning heavily on European health care and semiconductor powerhouses, with Roche and Novartis providing steady, rising support from the pharma side while ASML and Japan’s Advantest act as the fund’s turbochargers thanks to strong momentum in chip equipment. On the industrial front, Rolls-Royce and ABB add more cyclical punch, with Rolls-Royce climbing and ABB showing more mixed signals. Nestlé is losing a bit of steam, and SAP’s recent weakness is a mild drag, but overall the ETF’s performance is driven by developed markets outside the U.S., especially Europe and Japan.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 4.97% | $52.93M | $350.70B | 35.40% | 73 Outperform | |
| ASML Holding NV | 4.47% | $47.58M | €533.33B | 78.59% | 76 Outperform | |
| Novartis AG | 4.06% | $43.22M | CHF209.20B | 19.98% | 80 Outperform | |
| Nestlé SA | 3.32% | $35.34M | CHF199.76B | 3.56% | 71 Outperform | |
| SAP SE | 2.87% | $30.58M | €217.82B | -17.72% | 66 Neutral | |
| Rolls-Royce Holdings | 2.74% | $29.14M | £119.63B | 29.08% | 71 Outperform | |
| Allianz | 2.47% | $26.33M | €170.11B | 30.05% | 67 Neutral | |
| Recruit Holdings Co | 2.46% | $26.20M | ¥23.29T | 105.07% | 67 Neutral | |
| ABB Ltd | 2.38% | $25.35M | kr1.67T | 42.50% | 78 Outperform | |
| Advantest | 2.32% | $24.71M | ¥21.42T | 137.02% | 75 Outperform |
IDHQ Technical Analysis
Negative
―
Price Trends
44.48
Negative
42.80
Positive
39.62
Positive
Market Momentum
-0.30
Positive
40.18
Neutral
23.34
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDHQ, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 44.89, equal to the 50-day MA of 44.48, and equal to the 200-day MA of 39.62, indicating a neutral trend. The MACD of -0.30 indicates Positive momentum. The RSI at 40.18 is Neutral, neither overbought nor oversold. The STOCH value of 23.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IDHQ.
IDHQ Peer Comparison
Comparison Results
Performance Comparison
IDHQ
Invesco S&P International Developed High Quality ETF
43.79
10.87
33.02%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents